ReviewJournal of thoracic disease2026
Interventional techniques and strategies for postoperative bronchopleural fistula treatment: a narrative review.
Review in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Postoperative bronchopleural fistula (BPF), particularly bronchial stump dehiscence after anatomical lung resection, is distinct from alveolar-pleural fistula (APF), which typically arises from more peripheral parenchymal or subsegmental airway sources. Although uncommon, postoperative BPF can progress rapidly to pleural sepsis, aspiration, respiratory failure, and death. This narrative review summarizes contemporary evidence on bronchoscopic, surgical, and pleural-directed strategies for postoperative BPF and persistent/prolonged air leak (PAL) and proposes a practical multidisciplinary framework for treatment selection. Methods: A targeted PubMed/MEDLINE search was conducted on March 1, 2026, and supplemented by review of reference lists from key articles. Full-text studies, reviews, case series, and case reports describing postoperative BPF/PAL management after lung resection were considered, with emphasis on sealants or sclerosing agents, one-way endobronchial valves, silicone spigots, airway stents, occluder devices, and coil/embolization or pleural-directed strategies. Findings were synthesized narratively because definitions, anatomic descriptors, and outcomes were heterogeneous. Key Content and Findings: Durable closure rarely depends on a device alone. Initial priorities include airway protection, pleural drainage, infection source control, nutritional optimization, and reduction of airflow across the defect. Bronchoscopy localizes the culprit airway and can deliver targeted occlusion. For peripheral APF/PAL, removable one-way valves, silicone spigots, and selected coil/sealant approaches may be definitive in carefully selected patients. For central bronchial stump BPF, covered stents or occluder devices more often provide mechanical coverage as bridge therapy while pleural space infection and nutritional deficits are corrected; definitive surgical repair with vascularized muscle or omental flap reinforcement remains important for operable patients. Conclusions: No single modality is optimal for all postoperative airway-pleural communications. Treatment should be individualized according to timing after resection, central stump BPF versus peripheral APF/PAL phenotype, defect size, pleural space contamination, collateral ventilation, nutritional status, and patient operability. Contemporary multicenter data emphasize high mortality, the prognostic importance of albumin, hemoglobin, and systemic inflammation, and the frequent need for multimodal management. Prospective registries using standardized definitions and anatomy-specific endpoints are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.